Guchan Alanoglu
Süleyman Demirel University
13 Papers
90 Citations
Guchan Alanoglu is an academic researcher from Süleyman Demirel University. The author has contributed to research in topics: Myeloid leukemia & Comparative genomic hybridization. The author has an hindex of 7, co-authored 13 publications.
Chat about Author
Papers
Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
TL;DR: Plasma TAFI levels of PCOS patients were found to be significantly higher than in healthy controls, and plasma levels of D-dimer, AT III, PAI-1 and thrombomodulin were also significantly higher in women with PCOS compared with healthy controls.
35
Array comparative genomic hybridization analysis of adult acute leukemia patients.
Duygu Yasar,Ihsan Karadogan,Guchan Alanoglu,Bahar Akkaya,Guven Luleci,Ozan Salim,Ayşen Timurağaoğlu,Gokce Altay Toruner,Sibel Berker-Karauzum +8 more
TL;DR: The results demonstrate that oligo-array CGH (oaCGH) is an effective method for defining copy number alterations and identification of novel recurring unbalanced abnormalities and the use of oaCGH for routine diagnosis still has some restrictions.
24
Autoimmune hemolytic anemia during interferon-beta-I b treatment for multiple sclerosis.
TL;DR: It is concluded that if an unexplained drop in hematocrit occurs with a MS patient receiving IFNB-1b, autoimmune mediated hemolysis should also be considered.
17
Microsatellite Instability Is a Common Finding in Multiple Myeloma
TL;DR: Although the case number is small, probably the genomic instability in heavy-chain MM may be a common finding and probably plays a critical role in the MM pathogenesis.
16
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience
Demet Çekdemir,Serkan Güvenç,Fusun Ozdemirkiran,Ali Eser,Tayfur Toptas,Vildan Ozkocaman,Handan Haydaroglu Sahin,Esra Ermiş Turak,Ramazan Esen,Melda Cömert,Sevil Sadri,Müzeyyen Aslaner,Bahar Uncu Ulu,Abdullah Karakuş,Derya Selim Bapur,Inci Alacacioglu,Demet Aydin,Atakan Tekinalp,Sinem Namdaroglu,Funda Ceran,Pinar Tarkun,Demet Kiper,Mustafa Çetiner,Mustafa Nuri Yenerel,Ahmet Muzaffer Demir,Guven Yilmaz,Hatice Terzi,Erden Atilla,Umit Yavuz Malkan,Kadir Acar,Erman Öztürk,Anil Tombak,Cenk Sunu,Ozan Salim,Nevin Alayvaz,Özkan Sayan,Ülkü Ozan,Mesut Ayer,Zafer Gokgoz,Neslihan Andic,Ebru Kızılkılıç,Noyan F,Mehmet Özen,Funda Pepedil Tanrikulu,Guchan Alanoglu,Hasan Atilla Ozkan,Vahap Aslan,Güven Çetin,Alev Akyol Erikçi,Burak Deveci,Fadime Ersoy Dursun,Hasan Dermenci,Pelin Aytan,Mehmet Gunduz,Volkan Karakuş,Can Ozlu,Sinan Demircioğlu,Olga Meltem Akay Yanar,Düzgün Özatlı,Levent Undar,Eyup Naci Tiftik,Ayhan Gulsan Turkoz Sucak,Ibrahim C. Haznedaroglu,Muhit Ozcan,Mehmet Şencan,Murat Tombuloglu,Gülsüm Özet,Oktay Bilgir,Burhan Turgut,Mehmet Ali Özcan,Kadriye Bahriye Payzın,Mehmet Sönmez,Orhan Ayyildiz,Mehmet Sinan Dal,Sehmus Ertop,Mehmet Turgut,Teoman Soysal,Emin Kaya,Ali Ünal,Mustafa Pehlivan,Isik Kaygusuz Atagunduz,Tülin Tuğlular Fıratlı,Güray Saydam,Reyhan Diz Küçükkaya +83 more
TL;DR: Results of the current study imply that eltrombopag is an effective therapeutic option in even elderly patients with chronic ITP, however, patients must be closely monitored for response and side effects during treatment.
13